Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Investing Cash Flow

Investing Cash Flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$139M+27.6%
TFX
TeleflexTFX
-$74.79M-160%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$90M-13.6%
IAR
Integra LifeSciencesIART
-$14.85M+58.7%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$7.73M+126%
PDE
Pro-Dex, Inc.PDEX
$8.87M+1,736%

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's investing cash flow?
Utah Medical Products (UTMD) reported investing cash flow of -$130K in Q1 2026.
How has Utah Medical Products's investing cash flow changed year-over-year?
Utah Medical Products's investing cash flow increased by 29.3% year-over-year, from -$184K to -$130K.
What is the long-term trend for Utah Medical Products's investing cash flow?
Over 4 years (2021 to 2025), Utah Medical Products's investing cash flow has grown at a -9.5% compound annual growth rate (CAGR), from -$552K to -$371K.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.